1.15 (-%)
As of Nov 01, 2024
Source:
Artelo Biosciences, Inc is a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network throughout the body.
Country | United States |
Headquarters | solana beach, california |
Phone Number | 858-925-7049 |
Industry | manufacturing |
CEO | Gregory D. Gorgas |
Website | www.artelobio.com |